Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen

Clinical Nephrology

Volumn 68, Issue 2, 2007, Pages 125-129

  Gupta, S ^a   Woodrow, Graham ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Fulminant encapsulating peritoneal sclerosis; Fungal perotonitis; Inflammation; Malnutrition; Tamoxifen

Indexed keywords

ALBUMIN; AMPHOTERICIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CIPROFLOXACIN; FLUCONAZOLE; FLUCYTOSINE; ICODEXTRIN; METRONIDAZOLE; TAMOXIFEN;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL PERITONITIS; CANDIDA PARAPSILOSIS; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; FEVER; FULMINANT ENCAPSULATING PERITONEAL SCLEROSIS; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MALNUTRITION; NAUSEA; NEPHROSCLEROSIS; NEUTROPHIL; PERITONEAL DISEASE; PERITONEAL FLUID; PERITONITIS; SEPSIS; SYMPTOM; TOTAL PARENTERAL NUTRITION; ULTRAFILTRATION; VOMITING;

EID: 34547849545     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68125     Document Type: Article

References (24)

1. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent. J Nephrol. 1999; 12: 395-397.
2. Assalia A, Schein M, Hashmonai M. Problems in the surgical management of sclerosing encapsulating peritonitis Isr J Med Sci. 1993; 29: 686-688.
3. Bourouma R, Chevet D, Michel F, Cercueil JP, Arnould L, Rifle G. Treatment of idiopathic retroperitoneal fibrosis with tamoxifen. Nephrol Dial Transplant. 1997; 12: 2407-2410.
4. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis. 2006; 47: 697-712.
5. Courtney AE, Doherty CC. Fulminant sclerosing peritonitis immediately following acute bacterial peritonitis. Nephrol Dial Transplant. 2006; 21: 532-534.
6. Davies SJ, Philips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001; 12: 1046-1051.
7. Del Peso G, Bajo A, Gil F, Aguilera A, Ros S, Costero O, Jose Castro M, Selgas R. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial. 2003; 19: 32-35.
8. Denis J, Paineau J, Potel G, Fontenaille C, Guenel J. Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980; 93: 508.
9. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis - related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int. 2006; 26: 203-206.
10. Evrenkaya TR, Atasoyu TM, Unver S, Basekim C, Baloglu H, Tulbek MY. Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2004; 19: 2423-2424.
11. Fagugli RM, Selvi A, Quintaliani G, Bianchi M, Buoncristiani U. Immunosuppressive treatment for sclerosing peritonitis. Nephrol Dial Transplant. 1999; 14: 1343-1345.
12. Gandhi VC, Humayan HM, Ing TS, Daugirdas JT, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med. 1980; 140: 1201-1203.
13. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos D. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000; 20 (Suppl 4): S43-S55.
14. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, Tranaeus A. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment and preventive measures. Perit Dial Int. 2005; 25 (Suppl 4): S83-S95.
15. Kawanishi H, Kawaguchi Y, Fukui H et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004; 44: 729-737.
16. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int. 2005; 25 (Suppl 4): S39-S47.
17. Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ. Remission of rapidly growing desmoid tumours after tamoxifen therapy. Cancer. 1983; 52: 2201-2204.
18. Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001; 16: 1304-1305.
19. Overall CM, Wrana JL, Sodek JJ. Independent regulation of collagenase, 72Kd progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem. 1989; 264: 1860-1869.
20. Prasad N, Gupta A. Fungal peritonitis peritoneal dialysis patients. Perit Dial Int. 2005; 25: 207-222.
21. Rigby R, Hawley C. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998; 13: 154-159.
22. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. TGF β up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem. 1991; 266: 11436-11441.
23. Savelli BA, Parshley M, Morganroth ML. Successful treatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen. Chest. 1997; 111: 1137-1140.
24. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PEC, Augustine T, Riad H, Hutchison AJ, Taylor P, Pearson R, Gokal R. Single centre experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005; 68: 2381-2388.